These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 18937632

  • 1. Systemic sclerosis: an update.
    Varga J.
    Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
    [Abstract] [Full Text] [Related]

  • 2. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Co-Authors.
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanisms and consequences of fibrosis in systemic sclerosis.
    Denton CP, Black CM, Abraham DJ.
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):134-44. PubMed ID: 16932673
    [Abstract] [Full Text] [Related]

  • 5. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI.
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [Abstract] [Full Text] [Related]

  • 6. [Systemic sclerosis].
    Tamborrini G, Distler M, Distler O.
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [Abstract] [Full Text] [Related]

  • 7. Molecular pathways as novel therapeutic targets in systemic sclerosis.
    Trojanowska M, Varga J.
    Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
    [Abstract] [Full Text] [Related]

  • 8. Biomedical research. More than skin deep.
    Cahoon L.
    Science; 2008 Oct 31; 322(5902):667-9. PubMed ID: 18974325
    [No Abstract] [Full Text] [Related]

  • 9. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment].
    Zuber JP, Chizzolini C, Leimgruber A, Bart PA, Spertini F.
    Rev Med Suisse; 2006 Apr 19; 2(62):1058, 1060-6. PubMed ID: 16711151
    [Abstract] [Full Text] [Related]

  • 10. Animal models of scleroderma: lessons from transgenic and knockout mice.
    Derrett-Smith EC, Denton CP, Sonnylal S.
    Curr Opin Rheumatol; 2009 Nov 19; 21(6):630-5. PubMed ID: 19730378
    [Abstract] [Full Text] [Related]

  • 11. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M, Varga J.
    Am Fam Physician; 2008 Oct 15; 78(8):961-8. PubMed ID: 18953973
    [Abstract] [Full Text] [Related]

  • 12. Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
    Usategui A, del Rey MJ, Pablos JL.
    Expert Rev Clin Immunol; 2011 Jul 15; 7(4):491-8. PubMed ID: 21790292
    [Abstract] [Full Text] [Related]

  • 13. Skin involvement in scleroderma--where histological and clinical scores meet.
    Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P, Ertault M, Tiev K, Michel L, Mauviel A, Farge D.
    Rheumatology (Oxford); 2007 May 15; 46(5):833-41. PubMed ID: 17255134
    [Abstract] [Full Text] [Related]

  • 14. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
    Shiwen X, Leask A, Abraham DJ, Fonseca C.
    Eur J Clin Invest; 2009 Jun 15; 39 Suppl 2():19-26. PubMed ID: 19335743
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Management of patients with systemic sclerosis].
    Wiesik-Szewczyk E, Olesińska M.
    Pol Merkur Lekarski; 2010 May 15; 28(167):421-3. PubMed ID: 20568411
    [Abstract] [Full Text] [Related]

  • 18. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C, DNSS centers, Riemekasten G.
    Rheumatology (Oxford); 2009 Jan 15; 48(1):70-3. PubMed ID: 19056798
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M, Kaliterna DM, Fabijanić D, Radić J.
    Lijec Vjesn; 2010 Jan 15; 132(5-6):162-8. PubMed ID: 20677623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.